The Impact of HbA1c level on heart failure with recovered rjection fraction in patients with Type 2 Diabetes. (14th October 2021)
- Record Type:
- Journal Article
- Title:
- The Impact of HbA1c level on heart failure with recovered rjection fraction in patients with Type 2 Diabetes. (14th October 2021)
- Main Title:
- The Impact of HbA1c level on heart failure with recovered rjection fraction in patients with Type 2 Diabetes
- Authors:
- Yang, C.D
Wang, X.Q - Abstract:
- Abstract: Background: Heart failure (HF) with improved or recovered ejection fraction (EF, HFrecEF) has been recognized as a new type of HF with different underlying clinical phenotype, pathophysiology and prognosis. However, few studies have analyzed the relationship between type 2 diabetes and HFrecEF, and the impact of glycemic level on myocardial function recovery. Purpose: In the present study, we sought to investigate the relation between HbA1c level and HFrecEF in patients with type 2 diabetes. Methods: A total of 796 HF patients with reduced left-ventricular ejection fraction (LVEF, <40%) and type 2 diabetes were consecutively enrolled from August 2012 to July 2020. During follow-up for up to 24 months, patients were classified into HFrecEF for whom developed recovered LVEF (≥40% and absolute increase ≥5%) and HFrEF for whose LVEF was persistently reduced (<40%). The relation between HbA1c and the recovery of LV function was analyzed. Results: HF patients with type 2 diabetes had significantly lower rates of LVEF recovery when having higher versus lower HbA1c levels in the baseline (the lowest tertile: 62.4%, intermediate tertile: 50.4%, the highest tertile: 46.8%; P<0.001). There were stepwise decreases in changes of LVEF (P<0.001) and increases in changes of LV end-systolic diameter (LVESD; P=0.093) with increasing tertiles of LVEF during follow-up. In the subgroup analysis, the impact of HbA1c on LVEF recovery was more prominent in patients with ischemic heartAbstract: Background: Heart failure (HF) with improved or recovered ejection fraction (EF, HFrecEF) has been recognized as a new type of HF with different underlying clinical phenotype, pathophysiology and prognosis. However, few studies have analyzed the relationship between type 2 diabetes and HFrecEF, and the impact of glycemic level on myocardial function recovery. Purpose: In the present study, we sought to investigate the relation between HbA1c level and HFrecEF in patients with type 2 diabetes. Methods: A total of 796 HF patients with reduced left-ventricular ejection fraction (LVEF, <40%) and type 2 diabetes were consecutively enrolled from August 2012 to July 2020. During follow-up for up to 24 months, patients were classified into HFrecEF for whom developed recovered LVEF (≥40% and absolute increase ≥5%) and HFrEF for whose LVEF was persistently reduced (<40%). The relation between HbA1c and the recovery of LV function was analyzed. Results: HF patients with type 2 diabetes had significantly lower rates of LVEF recovery when having higher versus lower HbA1c levels in the baseline (the lowest tertile: 62.4%, intermediate tertile: 50.4%, the highest tertile: 46.8%; P<0.001). There were stepwise decreases in changes of LVEF (P<0.001) and increases in changes of LV end-systolic diameter (LVESD; P=0.093) with increasing tertiles of LVEF during follow-up. In the subgroup analysis, the impact of HbA1c on LVEF recovery was more prominent in patients with ischemic heart disease (P<0.001) than those with dilated cardiomyopathy (P=0.536). A significant interaction term was present between HbA1c and etiology of heart failure with regard to LVEF recovery (P=0.012). After multivariate adjustment of conventional confounding factors, high HbA1c level remained to be an independent risk factor lower incidence of HFrecEF in patients type 2 diabetes. Conclusions: Our study suggests that optimal glycemic control is an independent predictor for incidence of HFrecEF in patients with type 2 diabetes. Funding Acknowledgement: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): National Natural Science Foundation of China, Shanghai Municipal Commission of Health and Family Planning … (more)
- Is Part Of:
- European heart journal. Volume 42(2021)Supplement 1
- Journal:
- European heart journal
- Issue:
- Volume 42(2021)Supplement 1
- Issue Display:
- Volume 42, Issue 1 (2021)
- Year:
- 2021
- Volume:
- 42
- Issue:
- 1
- Issue Sort Value:
- 2021-0042-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-10-14
- Subjects:
- Systolic Ventricular Dysfunction
Cardiology -- Periodicals
Heart -- Diseases -- Periodicals
616.12005 - Journal URLs:
- http://eurheartj.oxfordjournals.org/ ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/eurheartj/ehab724.0763 ↗
- Languages:
- English
- ISSNs:
- 0195-668X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.717500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25015.xml